Comprehensive genetic analysis of the platelet activating factor acetylhydrolase (PLA2G7) gene and cardiovascular disease in case-control and family datasets

Beth S. Sutton, David R. Crosslin, Svati H. Shah, Sarah C. Nelson, Anthony Bassil, A. Brent Hale, Carol Haynes, Pascal Goldschmidt-Clermont, Jeffery M Vance, David M Seo, William E. Kraus, Simon G. Gregory, Elizabeth R. Hauser

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Platelet-activating factor acetylhydrolase (PLA2G7) is a potent pro- and anti-inflammatory molecule that has been implicated in multiple inflammatory disease processes, including cardiovascular disease. The goal of this study was to investigate the genetic effects of PLA2G7 on coronary artery disease (CAD) risk in two large, independent datasets with CAD. Using a haplotype tagging (ht) approach, 19 ht single nucleotide polymorphisms (SNPs) were genotyped in CATHGEN case-control samples (cases = 806 and controls = 267) and in the GENECARD Family Study (n = 1101 families, 2954 individuals). Single SNP analysis using logistic regression revealed nine SNPs with significant association in all CATHGEN subjects (P = 0.0004-0.02). CATHGEN cases were further stratified into subgroups based on age of CAD onset (AOO) and severity of disease; 599 young affecteds (YA, AOO <56) and 207 old affected (OA, AOO >56). Significant genetic effects were observed in both OA and YA (P = 0.0001-0.02). The GENECARD probands demonstrated results similar to those seen in the YA CATHGEN cases (P = 0.002-0.05). Of the 19 SNPs genotyped, 3 SNPs result in nonsynonymous coding changes (I198T, A379V and R92H). Two of the coding SNPs, R92H and A379V, constitute two of the most significantly associated SNPs, even after Bonferroni correction and appear to represent independent associations (r2 = 0.09). Multiple additional polymorphisms in low linkage disequilibrium with these coding SNPs were also strongly associated. In summary, PLA2G7 represents an important, potentially functional candidate in the pathophysiology of CAD based on replicated associations using two independent datasets and multiple statistical approaches. Further functional studies involving a combination of risk alleles are warranted.

Original languageEnglish
Pages (from-to)1318-1328
Number of pages11
JournalHuman Molecular Genetics
Volume17
Issue number9
DOIs
StatePublished - May 1 2008

Fingerprint

Platelet Activating Factor
Single Nucleotide Polymorphism
Cardiovascular Diseases
Genes
Coronary Artery Disease
Haplotypes
Datasets
Linkage Disequilibrium
Age of Onset
Anti-Inflammatory Agents
Logistic Models
Alleles

ASJC Scopus subject areas

  • Genetics

Cite this

Comprehensive genetic analysis of the platelet activating factor acetylhydrolase (PLA2G7) gene and cardiovascular disease in case-control and family datasets. / Sutton, Beth S.; Crosslin, David R.; Shah, Svati H.; Nelson, Sarah C.; Bassil, Anthony; Hale, A. Brent; Haynes, Carol; Goldschmidt-Clermont, Pascal; Vance, Jeffery M; Seo, David M; Kraus, William E.; Gregory, Simon G.; Hauser, Elizabeth R.

In: Human Molecular Genetics, Vol. 17, No. 9, 01.05.2008, p. 1318-1328.

Research output: Contribution to journalArticle

Sutton, BS, Crosslin, DR, Shah, SH, Nelson, SC, Bassil, A, Hale, AB, Haynes, C, Goldschmidt-Clermont, P, Vance, JM, Seo, DM, Kraus, WE, Gregory, SG & Hauser, ER 2008, 'Comprehensive genetic analysis of the platelet activating factor acetylhydrolase (PLA2G7) gene and cardiovascular disease in case-control and family datasets', Human Molecular Genetics, vol. 17, no. 9, pp. 1318-1328. https://doi.org/10.1093/hmg/ddn020
Sutton, Beth S. ; Crosslin, David R. ; Shah, Svati H. ; Nelson, Sarah C. ; Bassil, Anthony ; Hale, A. Brent ; Haynes, Carol ; Goldschmidt-Clermont, Pascal ; Vance, Jeffery M ; Seo, David M ; Kraus, William E. ; Gregory, Simon G. ; Hauser, Elizabeth R. / Comprehensive genetic analysis of the platelet activating factor acetylhydrolase (PLA2G7) gene and cardiovascular disease in case-control and family datasets. In: Human Molecular Genetics. 2008 ; Vol. 17, No. 9. pp. 1318-1328.
@article{17312cf715584152b9210c57f980960f,
title = "Comprehensive genetic analysis of the platelet activating factor acetylhydrolase (PLA2G7) gene and cardiovascular disease in case-control and family datasets",
abstract = "Platelet-activating factor acetylhydrolase (PLA2G7) is a potent pro- and anti-inflammatory molecule that has been implicated in multiple inflammatory disease processes, including cardiovascular disease. The goal of this study was to investigate the genetic effects of PLA2G7 on coronary artery disease (CAD) risk in two large, independent datasets with CAD. Using a haplotype tagging (ht) approach, 19 ht single nucleotide polymorphisms (SNPs) were genotyped in CATHGEN case-control samples (cases = 806 and controls = 267) and in the GENECARD Family Study (n = 1101 families, 2954 individuals). Single SNP analysis using logistic regression revealed nine SNPs with significant association in all CATHGEN subjects (P = 0.0004-0.02). CATHGEN cases were further stratified into subgroups based on age of CAD onset (AOO) and severity of disease; 599 young affecteds (YA, AOO <56) and 207 old affected (OA, AOO >56). Significant genetic effects were observed in both OA and YA (P = 0.0001-0.02). The GENECARD probands demonstrated results similar to those seen in the YA CATHGEN cases (P = 0.002-0.05). Of the 19 SNPs genotyped, 3 SNPs result in nonsynonymous coding changes (I198T, A379V and R92H). Two of the coding SNPs, R92H and A379V, constitute two of the most significantly associated SNPs, even after Bonferroni correction and appear to represent independent associations (r2 = 0.09). Multiple additional polymorphisms in low linkage disequilibrium with these coding SNPs were also strongly associated. In summary, PLA2G7 represents an important, potentially functional candidate in the pathophysiology of CAD based on replicated associations using two independent datasets and multiple statistical approaches. Further functional studies involving a combination of risk alleles are warranted.",
author = "Sutton, {Beth S.} and Crosslin, {David R.} and Shah, {Svati H.} and Nelson, {Sarah C.} and Anthony Bassil and Hale, {A. Brent} and Carol Haynes and Pascal Goldschmidt-Clermont and Vance, {Jeffery M} and Seo, {David M} and Kraus, {William E.} and Gregory, {Simon G.} and Hauser, {Elizabeth R.}",
year = "2008",
month = "5",
day = "1",
doi = "10.1093/hmg/ddn020",
language = "English",
volume = "17",
pages = "1318--1328",
journal = "Human Molecular Genetics",
issn = "0964-6906",
publisher = "Oxford University Press",
number = "9",

}

TY - JOUR

T1 - Comprehensive genetic analysis of the platelet activating factor acetylhydrolase (PLA2G7) gene and cardiovascular disease in case-control and family datasets

AU - Sutton, Beth S.

AU - Crosslin, David R.

AU - Shah, Svati H.

AU - Nelson, Sarah C.

AU - Bassil, Anthony

AU - Hale, A. Brent

AU - Haynes, Carol

AU - Goldschmidt-Clermont, Pascal

AU - Vance, Jeffery M

AU - Seo, David M

AU - Kraus, William E.

AU - Gregory, Simon G.

AU - Hauser, Elizabeth R.

PY - 2008/5/1

Y1 - 2008/5/1

N2 - Platelet-activating factor acetylhydrolase (PLA2G7) is a potent pro- and anti-inflammatory molecule that has been implicated in multiple inflammatory disease processes, including cardiovascular disease. The goal of this study was to investigate the genetic effects of PLA2G7 on coronary artery disease (CAD) risk in two large, independent datasets with CAD. Using a haplotype tagging (ht) approach, 19 ht single nucleotide polymorphisms (SNPs) were genotyped in CATHGEN case-control samples (cases = 806 and controls = 267) and in the GENECARD Family Study (n = 1101 families, 2954 individuals). Single SNP analysis using logistic regression revealed nine SNPs with significant association in all CATHGEN subjects (P = 0.0004-0.02). CATHGEN cases were further stratified into subgroups based on age of CAD onset (AOO) and severity of disease; 599 young affecteds (YA, AOO <56) and 207 old affected (OA, AOO >56). Significant genetic effects were observed in both OA and YA (P = 0.0001-0.02). The GENECARD probands demonstrated results similar to those seen in the YA CATHGEN cases (P = 0.002-0.05). Of the 19 SNPs genotyped, 3 SNPs result in nonsynonymous coding changes (I198T, A379V and R92H). Two of the coding SNPs, R92H and A379V, constitute two of the most significantly associated SNPs, even after Bonferroni correction and appear to represent independent associations (r2 = 0.09). Multiple additional polymorphisms in low linkage disequilibrium with these coding SNPs were also strongly associated. In summary, PLA2G7 represents an important, potentially functional candidate in the pathophysiology of CAD based on replicated associations using two independent datasets and multiple statistical approaches. Further functional studies involving a combination of risk alleles are warranted.

AB - Platelet-activating factor acetylhydrolase (PLA2G7) is a potent pro- and anti-inflammatory molecule that has been implicated in multiple inflammatory disease processes, including cardiovascular disease. The goal of this study was to investigate the genetic effects of PLA2G7 on coronary artery disease (CAD) risk in two large, independent datasets with CAD. Using a haplotype tagging (ht) approach, 19 ht single nucleotide polymorphisms (SNPs) were genotyped in CATHGEN case-control samples (cases = 806 and controls = 267) and in the GENECARD Family Study (n = 1101 families, 2954 individuals). Single SNP analysis using logistic regression revealed nine SNPs with significant association in all CATHGEN subjects (P = 0.0004-0.02). CATHGEN cases were further stratified into subgroups based on age of CAD onset (AOO) and severity of disease; 599 young affecteds (YA, AOO <56) and 207 old affected (OA, AOO >56). Significant genetic effects were observed in both OA and YA (P = 0.0001-0.02). The GENECARD probands demonstrated results similar to those seen in the YA CATHGEN cases (P = 0.002-0.05). Of the 19 SNPs genotyped, 3 SNPs result in nonsynonymous coding changes (I198T, A379V and R92H). Two of the coding SNPs, R92H and A379V, constitute two of the most significantly associated SNPs, even after Bonferroni correction and appear to represent independent associations (r2 = 0.09). Multiple additional polymorphisms in low linkage disequilibrium with these coding SNPs were also strongly associated. In summary, PLA2G7 represents an important, potentially functional candidate in the pathophysiology of CAD based on replicated associations using two independent datasets and multiple statistical approaches. Further functional studies involving a combination of risk alleles are warranted.

UR - http://www.scopus.com/inward/record.url?scp=42449096420&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=42449096420&partnerID=8YFLogxK

U2 - 10.1093/hmg/ddn020

DO - 10.1093/hmg/ddn020

M3 - Article

VL - 17

SP - 1318

EP - 1328

JO - Human Molecular Genetics

JF - Human Molecular Genetics

SN - 0964-6906

IS - 9

ER -